SLC7A11 and endometrial carcinoma: For example, in an endometrial carcinoma cohort (TCGA-UCEC), a higher percentage of cytotoxic T lymphocytes (CTLs) predicted a longer overall survival only in patients with lower SLC7A11 expression, which parallels the results of increased anticancer immunity with increased ferroptosis sensitivity (Fig. 4b).